Tempus AI
TEM
54.04
-5.57
-9.34%
Tempus AI
US · TEM
#1138 by market cap
Listed 2024
54.04
-5.57
-9.34%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions increased by 37 in the most recent period (2026/Q3).
- Total institutional ownership fell 2.3 percentage points.
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Institutional ownership
- Held by institutions
- 62.70% -2.26pp
- Institutions
- 613 +37
- As of
- 2026/Q3 vs. prior period
Holder types
Mutual Fund41.91%
Individual/Insider34.21%
Public Company10.50%
Private Company4.63%
Hedge Fund2.99%
Family Office/Trust0.97%
Government Pension Fund0.76%
Sovereign Wealth Fund0.53%
VC/PE Fund0.15%
Insurance Company0.17%
Other3.33%
Top holders as of 2026-10-27
Eric Lefkofsky
22.15% · 40.40M sh
Bradley Keywell
7.12% · 12.85M sh
ARK Investment Management LLC
5.49% · 10.02M sh
BlackRock
4.55% · 8.29M sh
Baillie Gifford
4.49% · 8.19M sh
Kimberly Keywell
4.42% · 8.06M sh
Vanguard Capital Management, LLC
3.11% · 5.66M sh
SoftBank Group Corp.
2.96% · 5.41M sh
Vanguard Portfolio Management, LLC
2.69% · 4.91M sh
Morgan Stanley
1.97% · 3.60M sh
Amova Asset Management
2.27% · 4.09M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 11 buys · 39 sells
| Name | Role | Stake |
|---|---|---|
| Eric Lefkofsky | Co-Founder, CEO, President & Chairman | 22.15% |
| Bradley Keywell | Co-Founder | 7.12% |
| Kimberly Keywell | -- | 4.42% |
| Ryan Fukushima | Chief Executive Officer of Data & Apps | 0.33% |
| Peter Barris | Independent Director | 0.06% |
| Theodore Leonsis | Independent Director | 0.04% |
| Erik Phelps | Executive VP and Chief Administrative & Legal Officer | 0.02% |
| Andrew Polovin | Chief Legal Officer | 0.02% |
| Tom Schoenherr | CEO of Ambry Genetics | 0.01% |
| Ryan Bartolucci | Chief Accounting Officer | 0.01% |
| Nadja West | Independent Director | 0.01% |
| Eric Belcher | Independent Director | 0.01% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-11-01 | David Epstein | Independent Director | Automatic Disposition | -370 | $74.29 |
| 2026-11-01 | Ryan Fukushima | Chief Executive Officer of Data & Apps | Other Acquisition | +100,000 | -- |
| 2026-11-01 | Ryan Fukushima | Chief Executive Officer of Data & Apps | Automatic Disposition | -80 | $74.29 |
| 2026-10-26 | Eric Lefkofsky | Co-Founder, CEO, President & Chairman | Automatic Disposition | -242,500 | $67.36–72.31 |
| 2026-09-24 | Tom Schoenherr | CEO of Diagnostics | Automatic Disposition | -10,281 | $85.00 |
| 2026-09-21 | Eric Lefkofsky | Co-Founder, CEO, President & Chairman | Automatic Disposition | -242,500 | $76.57–78.86 |
| 2026-09-16 | Eric Lefkofsky | Co-Founder, CEO, President & Chairman | Automatic Disposition | -192,500 | $80.52–81.09 |
| 2026-09-16 | Ryan Bartolucci | Chief Accounting Officer | Automatic Disposition | -7,062 | $75.00 |
| 2026-09-16 | Andrew Polovin | Chief Legal Officer | Automatic Disposition | -2,951 | $75.00 |
| 2026-09-15 | Ryan Fukushima | Chief Executive Officer of Data & Apps | Automatic Disposition | -700 | $70.00 |
| 2026-08-31 | David Epstein | Independent Director | Automatic Disposition | -250 | $65.55 |
| 2026-08-31 | Jennifer Doudna | Independent Director | Automatic Disposition | -676 | $65.55 |
| 2026-08-31 | Ryan Fukushima | Chief Executive Officer of Data & Apps | Automatic Disposition | -30,846 | $62.12–64.63 |
| 2026-08-27 | Nadja West | Independent Director | Automatic Disposition | -3,000 | $69.00 |
| 2026-08-20 | Tom Schoenherr | CEO of Diagnostics | Open Market Disposition | -2,694 | $70.00 |
| 2026-08-20 | Ryan Fukushima | Chief Executive Officer of Data & Apps | Open Market Disposition | -14,286 | $70.00 |
| 2026-08-18 | Tom Schoenherr | CEO of Diagnostics | Automatic Disposition | -8,082 | $55.97–61.23 |
| 2026-08-18 | Andrew Polovin | Chief Legal Officer | Automatic Disposition | -7,927 | $56.00 |
| 2026-08-18 | James Rogers | Chief Financial Officer | Automatic Disposition | -26,313 | $60.00 |
| 2026-08-17 | Eric Lefkofsky | Co-Founder, CEO, President & Chairman | Open Market Disposition | -132,591 | $49.61 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-11-20 20:02:25 · For reference only, not investment advice and not tailored to your situation.
Tempus AI discussion 0 comments